IPHA News
November 7, 2022
IPHA urges Government to heed slide in Europe’s research and development investments and clinical trials activity as policymakers in Brussels weigh legislative changes Europe could lose […]
November 4, 2022
The biopharmaceutical industry is surging. But believing that the surge is permanent, or inevitable, would be a mistake. Like other industries, we are buffeted by international […]
October 20, 2022
Comparator research, conducted by the Swedish Institute for Health Economics, finds: Cancer survival has improved since the 1990s but demographic pressures could push diagnoses to 42,000 […]
October 10, 2022
84% of people believe Ireland would be better prepared for another pandemic due to our experience with Covid-19 Trust in vaccines remains high, with 79% of […]
September 27, 2022
Budget’s €18m for new medicines falls short of amount needed to optimise patients’ access to innovation Originator industry acknowledges extraordinary pressures facing the Government but the […]
September 26, 2022
In the coming weeks, the Government will publish a White Paper on Enterprise. It will explore strategic policy options facing the enterprise sector. It comes as […]
September 14, 2022
Biogen’s Michael O’Connell named as new IPHA President Takeda’s Shane Ryan confirmed as Vice-President as industry focuses on a better environment for access, competitiveness and innovation […]
July 4, 2022
Two in five people believe pandemic will never be fully over, says Ipsos survey for IPHA Half of people believe Covid-19 pandemic will eventually end while […]
June 20, 2022
Sustained funding and an agile reimbursement system can improve care standards, writes Jim McGrath The reason medicines are reimbursed is that they improve the standard […]